is everyone on a glp 1 The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 There’s been a lot of

Not everyone, however, qualifies as a good candidate for this kind of treatment

doi: 10.1038/s41598-022-06463-6

The challenge is finding a plan that feels realistic and staying consistent with it over time

Labeling update (2026): The FDA recently removed suicidal behavior and ideation language from the labeling of certain GLP-1 medicines used for chronic weight management, following a comprehensive safety review that found no evidence of increased risk

Visit www.FunctionalMedicineUniversity.com for more information on our training in functional medicine

Just like GLP-1, GLP-1 receptor agonists signal the pancreas to produce more insulin and inhibit the production of glucagon, helping to lower blood sugar